Published on in Vol 9, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17735, first published .
Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Lubaba Shahrin 1, MBBS, FCPS;  Mohammod Jobayer Chisti 1, MBBS, MMed, PhD;  Abu Sadat Mohammad Sayeem Bin Shahid 1, MBBS;  Abu Sayem Mirza Mohammad Hasibur Rahman 1, MBBS;  Md. Zahidul Islam 1, MS;  Farzana Afroze 1, MBBS, FCPS;  Sayeeda Huq 1, MBBS, MPH;  Tahmeed Ahmed 1, MBBS, PhD

1 International Centre for Diarrheal Disease Research, Bangladesh , Dhaka , BD

Corresponding Author: